Atlas Trials

A Study to Evaluate the Drug Levels and Safety of Pegbelfermin in Healthy Overweight and Obese Chinese and Korean Participants

Clinical trial NCT04649710 · WITHDRAWN

Trial details

NCT number
NCT04649710
Sponsor
Bristol-Myers Squibb
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Participants
Start date
2021-06-21
Primary completion
2021-09-21
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.